Skip to main content
. 2009 May 18;53(8):3197–3204. doi: 10.1128/AAC.01681-08

FIG. 3.

FIG. 3.

Changes in pyrazinamide-resistant Mycobacterium tuberculosis burden with different dosing schedules. Doses that achieved the EC20 (A), EC40 (B), and EC60 (C) were administered by using different dosing schedules for each cumulative weekly dose.